Translational Medicine Academy

Wegbeschreibung Website Kontaktieren Sie die Praxis

Translational Medicine Academy BRIDGING THE GAPS BETWEEN KNOWLEDGE AND CARE – FASTER

TMA is a nonprofit advancing science to care.

We connect experts to speed clinical adoption and move innovation from lab to bedside through collaboration and translational research.

One patient. Type 2 diabetes, chronic kidney disease and heart failure.For clinicians, the shared risk factors are only ...
14/11/2026

One patient. Type 2 diabetes, chronic kidney disease and heart failure.

For clinicians, the shared risk factors are only the starting point. The harder questions follow: How do you assess kidney risk beyond eGFR? How do you manage hyperkalaemia without giving up guideline-directed therapy? Where does obesity treatment fit once heart failure is present?

This World Diabetes Day, revisit the e-SPACE HF 2026 sessions on cardiorenal syndrome, HFpEF, and cardiometabolic-kidney disease, available on demand.

Watch on demand: https://www.espace-hf.org/2026/

Effective heart failure treatment is not only about selecting the right therapies, it is also about whether patients can...
13/11/2026

Effective heart failure treatment is not only about selecting the right therapies, it is also about whether patients can continue them over time.

Join me at Updates in Heart Failure 2026 for “Polypharmacy, Adherence and Persistence”, part of Session 9: Delivering Better Heart Failure Care in 2026.
We’ll look at the practical challenges of treatment burden and what influences adherence and persistence in everyday heart failure care.

14–15 December 2026 | Stockholm, Sweden
Register now: https://tinyurl.com/4ptmbcjd

The connection between metabolic liver disease and heart failure is becoming increasingly important in clinical practice...
12/11/2026

The connection between metabolic liver disease and heart failure is becoming increasingly important in clinical practice.
I’m Nicolas Girerd, and at Updates in Heart Failure 2026, I’ll be presenting “Treating MASLD to Prevent Heart Failure: Are We Entering a New Era?” in Session 4: Emerging Therapies in Heart Failure.

I’ll be discussing the emerging evidence around MASLD and its implications for heart failure prevention, bringing the cardiovascular and metabolic perspectives together.

14–15 December 2026 | Stockholm, Sweden
Register now: https://tinyurl.com/4ptmbcjd

What remains to be addressed when heart failure progresses despite treatment?At Updates in HF global experts focus on re...
10/11/2026

What remains to be addressed when heart failure progresses despite treatment?
At Updates in HF global experts focus on residual risk, from ICD therapy and CRT to conduction system pacing, advanced HF referral and treatment.

Join global experts for practical discussion on recognising when patients need escalation and navigating the next steps in advanced heart failure care.

14–15 December 2026 | Stockholm, Sweden
Register now: https://tinyurl.com/4ptmbcjd

When CKD and heart failure coexist, managing one condition cannot be separated from the other.At Updates in Heart Failur...
08/11/2026

When CKD and heart failure coexist, managing one condition cannot be separated from the other.

At Updates in Heart Failure 2026, I’ll be addressing “Treating CKD & Heart Failure” in Session 2: Cardiorenal Syndrome 2026.
Join me in Stockholm for a focused look at the clinical challenges of treating these two closely connected conditions.

14–15 December 2026 | Stockholm, Sweden
Register now: https://tinyurl.com/4ptmbcjd

MOSAIC MASH 2026 brought the clinical trial community together to tackle one of the field’s biggest challenges: capturin...
07/11/2026

MOSAIC MASH 2026 brought the clinical trial community together to tackle one of the field’s biggest challenges: capturing treatment benefits across multiple organs.

130+ participants and 60+ faculty joined us in Washington, D.C., for two days of discussion on MASH/MASLD trial design, multi-organ endpoints, combination therapies and regulatory pathways.

The goal: move beyond liver-only outcomes and strengthen the evidence needed to evaluate therapies across the cardio-kidney-liver-metabolism (CKLM) spectrum.
Thank you to everyone who contributed to the discussions.

Pharmacological and device-based  approaches in the management of heart failure are making great progress. Explore emerg...
05/11/2026

Pharmacological and device-based approaches in the management of heart failure are making great progress. Explore emerging therapies of heart failure with 40+ global experts.

Join us to explore the emerging approaches across RNA and gene editing therapies, inflammation and fibrosis, including the role of MASLD treatment in preventing heart failure.

14–15 December 2026 | Stockholm, Sweden
Register now: https://tinyurl.com/4ptmbcjd

3,000+ live attendees joined the virtual event. Revisit the programme and its clinical insights on demand.Across 10 plen...
03/11/2026

3,000+ live attendees joined the virtual event. Revisit the programme and its clinical insights on demand.

Across 10 plenary sessions, international experts explored the latest HF guidelines, GDMT optimisation, HFrEF, HFpEF, cardiorenal care and emerging treatments.

Revisit key evidence and practical strategies to improve patient outcomes.
Watch on demand: https://www.espace-hf.org/2026/

The diagnosis and management of HFpEF remains a challenge for many clinicians. Session 3 of Updates in Heart Failure 202...
02/11/2026

The diagnosis and management of HFpEF remains a challenge for many clinicians.

Session 3 of Updates in Heart Failure 2026 looks at the different faces of HFpEF, from earlier recognition and foundational therapy to obesity-related, AF-dominant and hypertensive HFpEF. Join global experts for a focused discussion on recognising these different clinical presentations and translating the latest evidence into practical heart failure care.

14–15 December 2026 | Stockholm, Sweden
Register now: https://tinyurl.com/4ptmbcjd

Adresse

Picasso Platz 8
Basel
4052

Benachrichtigungen

Erfahren Sie als Erste/r von Neuigkeiten und Aktionen: Wir schicken Ihnen eine E-Mail, wenn Translational Medicine Academy etwas veröffentlicht. Ihre E-Mail-Adresse wird für keinen anderen Zweck verwendet, und Sie können sich jederzeit abmelden.

Kontaktieren Sie Die Praxis

Nachricht an Translational Medicine Academy senden:

Verknüpfungen

Teilen

Kliniken in der Nähe